FWM
VRTX icon

FSA Wealth Management’s Vertex Pharmaceuticals VRTX Stock Holding History

FSA Wealth Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		$7.44K Hold
19
– – ﹤0.01% 343
2025
Q2 		$8.46K Hold
19
– – ﹤0.01% 319
2025
Q1 		$9.21K Hold
19
– – ﹤0.01% 280
2024
Q4 		$7.65K Hold
19
– – ﹤0.01% 328
2024
Q3 		$8.84K Buy
+19
New +$9.13K ﹤0.01% 322
2024
Q1 		$7.94K Hold
19
– – ﹤0.01% 365
2023
Q4 		$8K Buy
+19
New +$7.02K ﹤0.01% 363

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

FSA Wealth Management's VRTX Position: Q3 2025 in Review

FSA Wealth Management held its Vertex Pharmaceuticals (VRTX) position steady in Q3 2025 at 19 shares worth $7.44K. The position accounts for ﹤0.01% of the portfolio, ranked #343.

FSA Wealth Management first reported a position in VRTX in Q4 2023 and has held it in 7 quarters since. The position peaked at $9.21K in Q1 2025. 1,519 funds tracked by Wall St. Rank hold VRTX as of Q3 2025.

  • FSA Wealth Management held 19 shares of Vertex Pharmaceuticals worth $7.44K as of Q3 2025.
  • FSA Wealth Management left its Vertex Pharmaceuticals share count unchanged in Q3 2025.
  • Vertex Pharmaceuticals made up ﹤0.01% of FSA Wealth Management's portfolio in Q3 2025, its #343 holding.
  • FSA Wealth Management first reported a position in Vertex Pharmaceuticals in Q4 2023 and has held it in 7 quarters since.
  • FSA Wealth Management's Vertex Pharmaceuticals position peaked at $9.21K in Q1 2025.
  • 1,519 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q3 2025.

Based on FSA Wealth Management's 13F filing for Q3 2025, filed 17 Nov 2025.